GENEREX BIOTECHNOLOGY CORP Contracts & Agreements

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 3, 2020)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on September 3, 2020)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on September 3, 2020)

NOTESETTLEMENT AGREEMENT (Filed With SEC on August 11, 2020)

Form of Series A Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series B Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series C Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series D Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Registration Rights Agreement dated as of August 4, 2020 between the Company and each other party a signatory thereto (Filed With SEC on August 7, 2020)

Securities Purchase Agreement dated as of August 4, 2020 between the Company and each buyer a signatory thereto (Filed With SEC on August 7, 2020)

THEISSUE PRICE OF THIS NOTE IS $50,000.00 (Filed With SEC on June 22, 2020)

THEISSUE PRICE OF THIS NOTE IS $100,000.00 (Filed With SEC on June 22, 2020)

WiringInstructions: SignatureBank 565Fifth Avenue NewYork, New York 10017 Routing#: 026013576 Account#: 1502765147 AccountTitle: Carmel, Milazzo & Feil LLP (Filed With SEC on June 22, 2020)

LaboratoryServices AGreement (Filed With SEC on June 8, 2020)

APPENDIXA- Statement of Work (Filed With SEC on June 8, 2020)

MASTER SERVICES AGREEMENT (Filed With SEC on March 17, 2020)

WHEREAS: (Filed With SEC on February 18, 2020)

Exhibit 3 Transfer Agent Instructions GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 18, 2020)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 18, 2020)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 18, 2020)

X = Y (A-B) A (Filed With SEC on February 18, 2020)

AMENDMENT AGREEMENT (Filed With SEC on January 28, 2020)

STOCK PURCHASE AGREEMENT CONFIDENTIAL DRAFT: for discussion Purposes ONLY (Filed With SEC on November 27, 2019)

RECITALS: (Filed With SEC on July 16, 2019)

AGREEMENT: (Filed With SEC on July 16, 2019)

RESTRUCTURING AGREEMENT (Filed With SEC on April 4, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 22, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 22, 2019)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 22, 2019)

BACKGROUND (Filed With SEC on February 22, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 15, 2019)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 15, 2019)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 15, 2019)

AMENDMENT AGREEMENT (Filed With SEC on January 22, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)

PROMISSORY NOTE CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on January 11, 2019)

AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (Filed With SEC on January 11, 2019)

MANAGEMENT SERVICES AGREEMENT (Filed With SEC on January 11, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)

PROMISSORY NOTE (Filed With SEC on January 11, 2019)

PLEDGE AND SECURITY AGREEMENT CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 11, 2019)

Formof Warrant To Purchase Common Stock (Filed With SEC on December 3, 2018)

STOCKCONTROL AGREEMENT (Filed With SEC on December 3, 2018)

AGREEMENT,ASSIGNMENT AND RELEASE (Filed With SEC on December 3, 2018)

SignaturePage to Follow (Filed With SEC on December 3, 2018)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on December 3, 2018)

NOTE DUENovember 26, 2019 (Filed With SEC on December 3, 2018)

STOCK PLEDGE AGREEMENT (Filed With SEC on December 3, 2018)

SignaturePage to Follow (Filed With SEC on November 30, 2018)

ClinicalTrial Agreement PHASEII STUDY between NSABPFoundation, Inc. and AntigenExpress, Inc. (Filed With SEC on November 26, 2018)

AMENDMENT to ASSETPURCHASE AGREEMENT (Filed With SEC on November 5, 2018)

PROMISORRYNOTE DUEJANUARY 15, 2019 (Filed With SEC on November 5, 2018)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 26, 2018)

NOTE DUEOCTOBER 26, 2019 (Filed With SEC on October 26, 2018)

STOCKPLEDGE AGREEMENT (Filed With SEC on October 26, 2018)

ASSETPURCHASE AGREEMENT (Filed With SEC on October 9, 2018)

PROMISSORYNOTE (Filed With SEC on October 9, 2018)

STOCKOPTION AGREEMENT (Filed With SEC on October 9, 2018)

CONFIDENTIALAMENDMENT TO SECURITIES PURCHASE AGREEMENT THISAMENDMENT (this “Amendment”) is made as of this day of June, 2018 by and between: GENEREXBIOTECHNOLOGY CORPORATION... (Filed With SEC on July 9, 2018)

LICENSEAND RESEARCH AGREEMENT BETWEEN ANTIGENEXPRESS, INC. (AWHOLLY-OWNED SUBSIDIARY OF GENEREXBIOTECHNOLOGY CORPORATION) AND SHENZHENBIOSCIEN PHARMACEUTICALS CO. LTD.... (Filed With SEC on December 12, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 29, 2017)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 29, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 6, 2017)

CONVERTIBLENOTE DUEMARCH ____, 2018 (Filed With SEC on March 6, 2017)

GENEREXBIOTECHNOLOGY CORPORATION NOTICETO WARRANT HOLDERS February__, 2017 (Filed With SEC on February 15, 2017)

RIGHTTO SHARES AGREEMENT (Filed With SEC on February 15, 2017)

ACQUISITIONAGREEMENT AMONG GENEREXBIOTECHNOLGY CORPORATION., a Delaware corporation, HEMADIAGNOSTIC SYSTEMS, LLC, a Florida limited liability company AND STEPHENL BERKMAN Andthe... (Filed With SEC on January 20, 2017)

PRIVATE ANDCONFIDENTIAL (Filed With SEC on January 20, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 25, 2015)

COMMONSTOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on June 25, 2015)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on June 25, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 28, 2014)

COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on March 28, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 28, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 15, 2014)

COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on January 15, 2014)

THIS OPTION HAS NOT BEEN REGISTERED UNDERTHE SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED UNLESSREGISTERED... (Filed With SEC on December 9, 2013)

OPTION AGREEMENT (Filed With SEC on December 9, 2013)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on November 1, 2013)

THIS OPTION HAS NOT BEEN REGISTERED UNDERTHE SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED UNLESSREGISTERED... (Filed With SEC on July 2, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 18, 2013)

COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on June 18, 2013)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 18, 2013)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on June 10, 2013)

SETTLEMENT AGREEMENTAND RELEASE (Filed With SEC on April 1, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 11, 2012)

COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on December 11, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 11, 2012)

THIS OPTION HAS NOT BEEN REGISTEREDUNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD OR OTHERWISETRANSFERRED UNLESS REGISTERED... (Filed With SEC on September 12, 2012)

THIS OPTION HAS NOT BEEN REGISTERED UNDERTHE SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED UNLESSREGISTERED... (Filed With SEC on September 12, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 8, 2012)

COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on August 8, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 8, 2012)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on June 22, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 1, 2012)

COMMON STOCK PURCHASE WARRANT generexbiotechnology corporation (Filed With SEC on February 1, 2012)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 1, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 11, 2011)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on July 11, 2011)

Summary of Compensation Arrangements with Executive Officers and Directors as of March 25, 2011 (Filed With SEC on June 3, 2011)

THIS OPTION HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD OR OTHERWISE TRANSFERRED UNLESS REGISTERED... (Filed With SEC on June 3, 2011)

OPTION AGREEMENT (Filed With SEC on June 3, 2011)

Generex Biotechnology Corporation 33 Harbour Square, Suite 202 Toronto, Ontario Canada M5J 2G2 (Filed With SEC on June 3, 2011)

COMMONSTOCK PURCHASE WARRANT GENEREXBIOTECHNOLOGY CORPORATION (Filed With SEC on January 25, 2011)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 25, 2011)

REDACTED AS FILED (Filed With SEC on December 11, 2009)

AtMarket Issuance Sales Agreement (Filed With SEC on October 15, 2009)

{00106182.DOC.2}MembersFINRA & SIPC 405 Lexington Ave. * NewYork, NY 10174 * tel ###-###-#### * (800) 724-0761 * fax ###-###-#### *www.maximgrp.com New York,NY * Long Island, NY *... (Filed With SEC on September 15, 2009)

COMMONSTOCK PURCHASE WARRANT GENEREXBIOTECHNOLOGY CORPORATION (Filed With SEC on September 15, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 15, 2009)

COMMONSTOCK PURCHASE WARRANT GENEREXBIOTECHNOLOGY CORPORATION (Filed With SEC on August 6, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on August 6, 2009)

COMMONSTOCK PURCHASE WARRANT GENEREXBIOTECHNOLOGY CORPORATION (Filed With SEC on June 16, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 16, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 18, 2009)

FORBEARANCEAND AMENDMENT AGREEMENT (Filed With SEC on March 2, 2009)

GenerexBiotechnology Corporation 33Harbour Square, Suite 202 Toronto,Ontario CanadaM5J 2G2 (Filed With SEC on February 17, 2009)

AGREEMENT (Filed With SEC on December 23, 2008)

GENEREX BIOTECHNOLOGY CORPORATION Annual Base Salaries for Executive Officers Effective January1, 2008 (Filed With SEC on October 10, 2008)

Summary of Compensation of the Directors of Generex Biotechnology Corporation (Filed With SEC on October 10, 2008)

CONSENT AND WAIVER (Filed With SEC on August 1, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 2, 2008)

[FORM OF SENIOR SECURED CONVERTIBLE NOTE] (Filed With SEC on April 2, 2008)

[FORM OF SERIES A WARRANT] (Filed With SEC on April 2, 2008)

[FORM OF SERIES A-1 WARRANT] (Filed With SEC on April 2, 2008)

[FORM OF SERIES B WARRANT] (Filed With SEC on April 2, 2008)

[FORM OF SERIES C WARRANT] (Filed With SEC on April 2, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 2, 2008)

SECURITY AGREEMENT (Filed With SEC on April 2, 2008)

GUARANTY (Filed With SEC on April 2, 2008)

Summary of Compensation of the Directors of Generex Biotechnology Corporation (Filed With SEC on October 15, 2007)

GENEREX BIOTECHNOLOGY CORPORATION 2006 STOCK PLAN RESTRICTED STOCK AGREEMENT (Filed With SEC on August 23, 2007)

GENEREX BIOTECHNOLOGY CORPORATION Annual Base Salaries for Executive Officers Effective August 1, 2005 and January1, 2007 (Filed With SEC on August 23, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase n Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 16, 2006)

6% SECURED CONVERTIBLE DEBENTURE DUE MAY 28, 2007 (Filed With SEC on October 16, 2006)

COMMON STOCK PURCHASE WARRANT To Purchase 800,000 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 16, 2006)

REDACTED - AS FILED THE MARKED PORTIONS OF THIS AMENDMENT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT Quotation (Filed With SEC on October 16, 2006)

REDACTED - AS FILED (Filed With SEC on October 16, 2006)

REDACTED - AS FILED THE MARKED PORTIONS OF THIS CLINICAL SUPPLY AGREEMENT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL... (Filed With SEC on October 16, 2006)

GENEREX BIOTECHNOLOGY CORPORATION WARRANT (Filed With SEC on June 14, 2006)

WARRANT (Filed With SEC on June 14, 2006)

Exhibit 4.1 (Filed With SEC on June 2, 2006)

Exhibit 4.2 EXHIBIT A (Filed With SEC on June 2, 2006)

Exhibit 4.3 (Filed With SEC on June 2, 2006)

Exhibit 4.4 EXHIBIT A (Filed With SEC on June 2, 2006)

COMMON STOCK PURCHASE WARRANT To Purchase 200,000 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on March 7, 2006)

Exhibit 4.1 (Filed With SEC on January 24, 2006)

EXHIBIT 4.2 (Filed With SEC on January 24, 2006)

AMENDMENT NO. 4 TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 20, 2006)

6% SECURED CONVERTIBLE DEBENTURE DUE MAY 20, 2007 (Filed With SEC on January 20, 2006)

COMMON STOCK PURCHASE WARRANT To Purchase 952,381 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on January 20, 2006)

ADDITIONAL INVESTMENT RIGHT To Purchase $1,000,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on January 20, 2006)

6% SECURED CONVERTIBLE DEBENTURE DUE JANUARY 27, 2007 (Filed With SEC on December 15, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 609,756 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on December 15, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 1,829,268 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on December 15, 2005)

AMENDMENT NO. 3 TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 5, 2005)

6% SECURED CONVERTIBLE DEBENTURE DUE APRIL 5, 2007 (Filed With SEC on December 5, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 1,219,512 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on December 5, 2005)

ADDITIONAL INVESTMENT RIGHT To Purchase $1,000,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on December 5, 2005)

Re: Generex Biotechnology Corporation - Amendment to Jun 17 05 Warrant (Filed With SEC on October 31, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 31, 2005)

6% SECURED CONVERTIBLE DEBENTURE DUE SEPTEMBER 16, 2006 (Filed With SEC on October 31, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 609,756 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 31, 2005)

ADDITIONAL INVESTMENT RIGHT To Purchase $500,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on October 31, 2005)

Generex Biotechnology Corporation 33 Harbour Square, Suite 202 Toronto, Ontario Canada M5J 2G2 (Filed With SEC on October 31, 2005)

WARRANT (Filed With SEC on October 31, 2005)

Generex Biotechnology Corporation 33 Harbour Square, Suite 202 Toronto, Ontario Canada M5J 2G2 (Filed With SEC on October 31, 2005)

WARRANT (Filed With SEC on October 31, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 300,000 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 31, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 609,756 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 31, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on October 31, 2005)

AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 9, 2005)

6% SECURED CONVERTIBLE DEBENTURE DUE DECEMBER 8 2006 (Filed With SEC on September 9, 2005)

COMMON STOCK PURCHASE WARRANT To Purchase 609,756 Shares of Common Stock of GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on September 9, 2005)

ADDITIONAL INVESTMENT RIGHT To Purchase $500,000 Principal Amount of 6% Convertible Debentures and Warrants Generex Biotechnology Corporation (Filed With SEC on September 9, 2005)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 17, 2005)

(1) ELAN CORPORATION, PLC (2) ELAN INTERNATIONAL SERVICES, LTD (3) GENEREX BIOTECHNOLOGY CORPORATION AND (4) GENEREX (BERMUDA), LTD (Filed With SEC on June 14, 2005)

Warrant No.: 2005____ Number of Shares: 100,000Date of Original Issuance: April 28, 2005 (Filed With SEC on June 14, 2005)

Warrant No.: 2005_____ Number of Shares: 1,219,512Date of Original Issuance: April 28, 2005 (Filed With SEC on June 14, 2005)

Principal: $100,000 Dated: April 4, 2005 Interest Rate: 10% Maturity Date: May 15, 2005 (Filed With SEC on June 14, 2005)

Warrant No.: 2005_____ Number of Shares: 243,902Date of Original Issuance: April 28, 2005 (Filed With SEC on June 14, 2005)

Category

Industry

Companies

Contracts

GENEREX BIOTECHNOLOGY CORP Contracts & Agreements